Tufts CSDD is conducting an important new survey to assess how pharma and biotech companies are incorporating patient engagement into their drug development organizations and operations. The survey is very brief — it should take only 20-25 minutes to complete. The results of this study will characterize how companies are structured to support patient engagement and where they are directing their resources and investment. Click on the link below to access the survey.
All responses are confidential and will only be reported in the aggregate.
For more information, contact Dr. Jennifer Kim, Assistant Professor, Tufts CSDD